产孢丝状真菌体外药敏试验方法及相关研究进展
被引量:3
摘要
概述了自M38-P方案用于产孢丝状真菌体外药敏试验以来,其应用范围、技术手段、终点判定及结果分析等相关研究进展,介绍了产孢丝状真菌联合药敏试验方法及应用,为临床治疗机会性真菌感染提供具有指导意义的用药选择和效果预测。
出处
《国外医学(皮肤性病学分册)》
2003年第6期382-384,共3页
Foreign Medical Sciences(Section of Dermatology and Venereology)
参考文献20
-
1Barchiesi F, Falconi Di Francesco L, Scalise G. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles. Antimicrob Agents Chemother, 1997.41 (8) :1812 - 1814.
-
2Ryder NS, Leitner I. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species. Med Mycol,2001.39(1) :91 -95.
-
3Kontoyiannis DP, Lewis RE, Sagar N, et al. Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: an E-test-based strategy.Antimicrob Agents Chemother, 2000, 44(10) :2915 -2918.
-
4Te Dorsthorst DT, Verweij PE, Meis JF, et al. Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolates. Antimicrob Agents Chemother, 2002, 46(3) :702 -707.
-
5Rex JH, Pfaller MA, Walsh TJ, et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev,2001, 14(4) :643 -658.
-
6Denning DW, Radford SA, Oakley KL,et al. Correlation between invitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother, 1997, 40(3) :401 -414.
-
7Manavathu EK, Cutright J, Chandrasekar PH. Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antffungal agents. J Clin Microbiol, 1999, 37(3) :858 -861.
-
8Pfaller MA, Messer SA, Mills K, et al. In vitro susceptibility testing of filamentous fungi : comparison of Etest and reference microdilution methods for determining itraconazole MICs. J Clin Microbiol, 2000,38(9) :3359 -2261.
-
9Szekely A, Johnson EM, Warnock DW. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J Clin Microbiol, 1999, 37 ( 5 ) : 1480 - 1483.
-
10Espinel-Ingroff A. Comparison of the E-test with the NCCLS M38 - P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J Clin Microbiol, 2001 , 39 (4) :1360.
同被引文献29
-
1刘嘉德,蒋秀芳.井冈霉素、烯唑醇及其混剂对稻曲病菌毒力测定[J].现代农药,2005,4(1):31-32. 被引量:6
-
2夏晓明,王开运,范昆,胡燕,刘振龙.抗戊唑醇禾谷丝核菌的渗透压敏感性及相对渗率变化研究[J].农药学学报,2005,7(2):126-130. 被引量:29
-
3Gupta AK, Konnikov N, Lynde CW. Sequential pulse therapy with itraconazole and terbinafine to treat onychomycosis of the fingernails.J Dennatol Treat 2000; 11 : 151 - 154.
-
4Gupta AK, Lynde CW, Konnikov N. Single- blind, randomized,prospective study of Sequential itraconazole and terbinafine pulse for the treatment of toenail onychomycosis. J Am Aead Dermatol 2001 ;44:485 - 491.
-
5Ryder NS, Leitner I. Synergistic interaction of terbinafine with triazole or amphotericin B against Aspergillus species. Med Mycol 2001 ;39:91 - 95.
-
6Rashid A, Scott EM, Richardson MD. Inhibitory effect of terbinafine on the invasion of nail by Trichophyton mentagrophytes. J Am Acad Dennatol 1995 ; 33 : 718 - 723.
-
7Maesaki S, Kohno S, Kaku M, et al. Effects of Antifungal Agent combination administered simultaneously and sequentially against Aspergillus fumigatus. Antimicrob Agents Chemother 1994 ; 38 : 2843 -2845.
-
8National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing
-
9Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast. M-27A. NCCLS,1997
-
10Mock M, Monod M, Baudraz-Rosselet F, et al. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo, Dermatology, 1998;197(4): 361 -367
引证文献3
-
1胡晓莉,杨森,张书梅,杨春俊,杜文辉,林达,朱一元.体外观察特比萘芬联合伊曲康唑对须癣毛癣菌甲侵袭的抑制作用[J].中国麻风皮肤病杂志,2005,21(10):779-781.
-
2邓淑文,哈木拉提.百癣夏塔热体外抗真菌活性研究[J].中药药理与临床,2006,22(3):166-169. 被引量:13
-
3刘韵怡,戚建华,王年,郁小娟,何轩灏,刘轩明,宋增福.生物表面活性剂鼠李糖脂对寄生水霉的体外抑制作用[J].大连海洋大学学报,2022,37(1):95-103. 被引量:1
二级引证文献14
-
1李治建,古力娜.达吾提,斯拉甫.艾白.地锦草提取物体外抗真菌作用研究[J].时珍国医国药,2008,19(12):2958-2960. 被引量:11
-
2李治建,斯拉甫·艾白,古力娜·达吾提,肖威,安惠霞.地锦草不同提取部位抗皮肤癣菌作用[J].石河子大学学报(自然科学版),2008,26(6):735-738. 被引量:10
-
3李治建,古力娜.达吾提,肖威,斯拉甫.艾白.地锦草提取物抗真菌作用及对皮肤真菌超微结构的影响[J].中草药,2009,40(5):758-763. 被引量:13
-
4古力娜.达吾提,斯拉甫.艾白,李治建,安惠霞,高莉,彭晓明.地锦草提取物抗真菌作用及对红色毛癣菌角鲨烯环氧化酶的影响[J].医药导报,2009,28(11):1404-1407. 被引量:3
-
5屠辉辉,赵怀智.百癣夏塔热片治疗成人脂溢性皮炎的临床观察[J].中国医药指南,2010,8(27):109-110. 被引量:7
-
6周军,李茂.抗真菌药物的研究进展[J].内科,2010,5(5):531-533.
-
7谢奇,李治建,斯拉甫.艾白,古力娜.达吾提,周露.地锦草化学成分及其抗真菌作用的研究进展[J].医药导报,2011,30(7):880-883. 被引量:15
-
8周露,斯拉甫.艾白,李治建,古力娜.达吾提,安惠霞.地锦草不同醇浓度提取物体外抗真菌作用研究[J].时珍国医国药,2011,22(5):1106-1107. 被引量:1
-
9刘中华,张慧敏.脂溢性皮炎与马拉色菌的关系及相关治疗研究进展[J].辽宁中医药大学学报,2012,14(5):82-85. 被引量:4
-
10牟萍,丁敏,安徐生,李晶冰,王艳.百癣夏塔热胶囊联合特比萘芬治疗趾甲真菌病46例的临床疗效[J].现代生物医学进展,2012,12(36):7113-7115. 被引量:1
-
1沈金雄,张嵘,王红宇.NCCLS肉汤稀释法检测产孢丝状真菌药物敏感试验的应用[J].中国感染控制杂志,2003,2(1):11-13. 被引量:2
-
2周勇.产孢丝状真菌体外药敏试验[J].中国药物应用与监测,2005,2(5):42-45.
-
3唐晓红,王亚婷,郝慧华,郭芳.铜绿假单胞菌237株耐药性分析[J].中国误诊学杂志,2008,8(8):1985-1985. 被引量:1
-
4袁立燕,黄怀球,张静.2008年版美国临床实验室标准化委员会产孢丝状真菌药敏试验方案简读[J].皮肤性病诊疗学杂志,2012,19(5):309-311. 被引量:4
-
5李厚敏,刘伟,李若瑜.美国临床实验室标准化委员会2003年版产孢丝状真菌药敏试验方案简介[J].中华检验医学杂志,2005,28(1):121-123. 被引量:26
-
6张静萍,朱婉,褚云卓,陈佰义.连续6年凝固酶阴性葡萄球菌的耐药性监测[J].中华医院感染学杂志,2009,19(11):1410-1412. 被引量:18
-
7张嵘,金亚平,朱百荣,周俊.Sensititre Yeastone比色抗真菌药敏试验检测产孢丝状真菌MICs的应用评价[J].中华微生物学和免疫学杂志,2002,22(6):689-689. 被引量:2
-
8钟巧,李晖,高晓玲,刘珺,靳淑雁,姚吉龙.NICU病原菌变化特点研究[J].中华医院感染学杂志,2013,23(11):2751-2753. 被引量:2
-
9董平,万喆,李若瑜.抗真菌药单独及联合应用对曲霉菌的体外药敏试验研究[J].中华检验医学杂志,2003,26(9):527-529. 被引量:25
-
10王晓俭,强新.特比奈芬对皮肤致病性产孢丝状真菌的药敏试验[J].齐鲁医学杂志,2006,21(4):321-322. 被引量:1